Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB1 | P05556 | 4/20 | 0.45 |
| ▸ | ITGA4 | P13612 | 4/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.42 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5708335 | 0.87 | ITGB1 (0.53) | ITGB1ITGA4MAPTALDH1A1RECQL | |
| SCHEMBL2429778 | 0.86 | ITGB1 (0.51) | ITGB1ITGA4S1PR2MAPTPOLB | |
| SCHEMBL92337 | 0.81 | BRPF1 (0.50) | S1PR2MAPTPOLBBRD4BRPF1 | |
| SCHEMBL2429782 | 0.76 | MEN1 (0.48) | ITGB1ITGA4S1PR2MAPTPOLB | |
| SCHEMBL2435704 | 0.75 | ITGB1 (0.51) | ITGB1ITGA4MAPTPOLBNR4A2 | |
| SCHEMBL5457279 | 0.75 | ITGB1 (0.49) | ITGB1ITGA4MAPTPOLBALDH1A1 | |
| SCHEMBL92336 | 0.74 | MEN1 (0.55) | S1PR2MAPTPOLBBRD4BRPF1 | |
| SCHEMBL91559 | 0.73 | ITGB1 (0.49) | ITGB1ITGA4MAPTPOLBNR4A2 | |
| SCHEMBL72352 | 0.73 | POLB (0.61) | ITGB1ITGA4S1PR2MAPTPOLB | |
| SCHEMBL14591773 | 0.73 | POLB (0.58) | ITGB1ITGA4S1PR2MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070149606-A1 | Process for producing phenylacetic acid derivative | DAIICHI PHARMACEUTICAL CO.,LTD. (JP) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149606-A1 | Process for producing phenylacetic acid derivative | UGT1A4, VPS4B, CYP3A4 | ITGB1 1987/4885ITGA4 106/4885S1PR2 3875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.